Ryan Specialty Holdings stock
RYANNYSERyan Specialty Holdings, Inc., Financial ServicesISIN US78351F1075
64Score 64 out of 100, Neutral
Price and trend
87 / 100
Price history
−19% in one yearThe chart shows daily closes over 5 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Above the 200-day line: the price is 19% above it.
Since September 2026 the 50-day line has been above the 200-day line; the trend has turned up.
Normal: the price is neither overheated nor sold off (RSI 61).
The price is 21% below its 52-week high. Largest decline in 5 years: 61% (April 2025 to May 2026).
Chart figures for advanced users
- SMA 50$41.09
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$38.84
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)61
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$29.39
- The lowest closing price of the last twelve months.
- Resistance$58.38
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Ryan Specialty Holdings, Inc. belongs to the Insurance (Brokers) industry (United States) and, with a market value of $5.52B, is number 6 of 15 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $3.05B (up 21.3% year on year) and earnings of $63.4M (down 33%).
- For fiscal 2026, analysts expect on average revenue of $3.29B (up 7.7%) and adjusted earnings per share of $2.18 (up 10.6%).
Show more
- MEQIRI Score 64 out of 100 (Neutral): rank 630 of 975 in Financial Services, median 68.
- The P/E is 115.6 (Insurance (Brokers) median 24.6, own median of recent years 78.9).
- Our model puts fair value at $31.38, with the price 47% above it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Earnings turn into cashFree cash flow 479% of earnings over the last 12 months.Fundamentals 90
- Growing faster than its industryRevenue up 24.5% a year since 2020, Insurance (Brokers) median 13.2%.Growth 81
Weaknesses
- Richly valuedP/E 115.6, Insurance (Brokers) median 24.6, own median 78.9.Valuation 25
- High debtDebt 4.28 times equity (latest quarter), Insurance (Brokers) median 0.77.Stability 30
- Margin may fall backOperating margin 20.5%, average of the prior years 10.4%, which ranged from 4.3% to 11.5%. After peaks like this, the margin was more than a quarter lower two years later in 44 of 100 cases, against 24 of 100 for other companies with high margins.Profitability 62
Its standout strengths are fundamentals and technical analysis, while stability and valuation hold the score back.
Daily figure as of 13 Nov 2026
How the score is calculatedScore overview
Score since yesterday from 65 to 64.
Fundamentals are strong, with stable profits and strong cash generation.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk medium
How well MEQIRI warnsIn the middle among smaller stocks.
From 2016 to 2025, 20 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.
What drives the risk
- high price swings
- high growth grade (crashed more often in the backtest)
What lowers it
- solid fundamentals
Valuation
Valuation signal
Modestly overvaluedIn our model the price counts as cheap below $22.42 and expensive above $52.30 (uncertainty high, based on the price swings of the past year).
The two parts of the fair value come to $52.95 (cash-flow model) and $9.82 (industry comparison), and the gap between them shows how uncertain the estimate is.
Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $26.93, at 7.8% it would be $38.07.
Valuation metrics
Half from the cash-flow model, half from earnings times the industry P/E (24.6).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue rose 9.8% on the twelve months before. Revenue has grown strongly since 2019, at around 26% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 91%, operating 20%, net 2%.
Debt & balance sheet
latest quarterDebt is elevated. Keep an eye on the interest burden and refinancing.
Earnings
- Next earnings
- 11 Feb 2027in 90 days
- Last reported
- 29 Oct 2026EPS reported $0.51 (expected $0.49)above expectations
Analyst estimates
Earnings estimates have barely changed since 15 Oct 2026.
- Earnings per share
- $2.18+0.7%
- Revenue
- $3.29B−0.2%
- Earnings per share
- $2.42−0.4%
- Revenue
- $3.51B−0.5%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook raised
Share price after the results: −5.0%2026 organic revenue growth now expected toward the higher end of the mid single digit range; margin guidance raised by 0.5 points at both ends (decline now 0.5 to 1 point).
The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 30 Jul 2026 (fiscal Q2 2026), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
5 insiders bought on the open market between 3 Jun 2026 and 12 Jun 2026, $4.57M in total. 3 insiders sold, $6.43M in total.
Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.
- Wuller Benjamin MIlesSale
10 Nov 2026, CEO RSUM
- Shares
- 50,000
- Price
- $47.18
- Value
- $2.36M
- Wuller Benjamin MIlesSale
9 Nov 2026, CEO RSUM
- Shares
- 50,000
- Price
- $47.31
- Value
- $2.37M
- Mulshine Brendan MartinSale
8 Sept 2026, Co-President and CRO
- Shares
- 40,000
- Price
- $40.51
- Value
- $1.62M
Show 7 more
- Conklin MichaelSale
13 Aug 2026, EVP & CHRO
- Shares
- 2,043
- Price
- $42.26
- Value
- $86,344
- Kuczinski Anthony JPurchase
12 Jun 2026, Board
- Shares
- 500
- Price
- $35.77
- Value
- $17,885
- Kuczinski Anthony JPurchase
11 Jun 2026, Board
- Shares
- 2,500
- Price
- $34.83
- Value
- $87,075
- Rogers John W JrPurchase
10 Jun 2026, Board
- Shares
- 7,500
- Price
- $35.16
- Value
- $263,732
- Ryan Patrick GPurchase
5 Jun 2026, 10 percent owner, officer: Executive Chairman
- Shares
- 120,000
- Price
- $32.50
- Value
- $3.9M
- Hamilton Janice MPurchase
3 Jun 2026, Chief Financial Officer
- Shares
- 6,300
- Price
- $31.79
- Value
- $200,293
- Katz Mark StephenPurchase
3 Jun 2026, EVP & General Counsel
- Shares
- 3,215
- Price
- $31.07
- Value
- $99,888
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at Ryan Specialty Holdings
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
975 rated companies in Financial Services
- This company
- 64
- Sector median
- 68
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Insurance (Brokers)
The next larger and next smaller companies by market value
- Arthur J. GallagherAJG $71.1B66
- AonAON $70.74B74
- Willis Towers Watson PublicWTW $30.32B75
- Brown & BrownBRO $23.4B71
- PB FintechPOLICYBZR.NS $5.16B51
- CorVelCRVL $4.35B79
- Neptune Insurance HoldingsNP $3.92B66
- Baldwin Insurance GroupBWIN $2.98B48
ETFs that hold Ryan Specialty Holdings
Held by 10 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| State Street SPDR S&P 400 U.S. Mid Cap UCITS ETF (Acc)SPY4 | 0.16% | 0.30% | €5.36B |
| State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETFZPRV | 0.06% | 0.30% | €964.08M |
| iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETFSXRG | 0.05% | 0.43% | €2.5B |
Show 5 more
| iShares MSCI World Small Cap UCITS ETFIUSN | 0.05% | 0.35% | €8.27B |
| UBS MSCI USA Select Factor Mix UCITS ETF USD accUSUE | 0.01% | 0.25% | €178.55M |
| iShares MSCI World Small Cap CTB Enhanced ESG UCITS ETFCBUG | 0.01% | 0.10% | €395.74M |
| Vanguard ESG Global All Cap UCITS ETF (USD) AccumulatingV3AA | 0.00% | 0.24% | €1.69B |
| Vanguard FTSE Global All-Cap UCITS ETF Accum USDVGLA | 0.00% | 0.07% | €3.9B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 24 Apr 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.